Production, characterization, and epitope mapping of monoclonal antibodies of ribosomal protein S3 (rpS3)
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ahn, Woo-Sung | - |
dc.contributor.author | Kim, Tae-Sung | - |
dc.contributor.author | Park, Yong Jun | - |
dc.contributor.author | Park, Young Kwang | - |
dc.contributor.author | Kim, Hag Dong | - |
dc.contributor.author | Kim, Joon | - |
dc.date.accessioned | 2022-02-21T13:42:44Z | - |
dc.date.available | 2022-02-21T13:42:44Z | - |
dc.date.created | 2022-02-08 | - |
dc.date.issued | 2021-09-03 | - |
dc.identifier.issn | 1976-8354 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/136388 | - |
dc.description.abstract | Ribosomal protein S3 (rpS3), a member of 40S small ribosomal subunit, is a multifunctional protein with various extra-ribosomal functions including DNA repair endonuclease activity and is secreted from cancer cells. Therefore, antibodies with high specificity against rpS3 protein could be useful cancer biomarkers. In this study, polyclonal antibody (pAb) and monoclonal antibodies (mAbs) were raised against rpS3 protein and epitope mapping was performed for each antibody; the amino acid residues of rpS3 were scanned from amino acid 185 to 243 through peptide scanning to reveal the epitopes of each mAb. Results showed that pAb R2 has an epitope from amino acid 203 to 230, mAb M7 has an epitope from amino acid 213 to 221, and mAb M8 has an epitope from amino acid 197 to 219. Taken together, novel mAbs and pAb against rpS3 were raised and mapped against rpS3 with different specific epitopes. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | TAYLOR & FRANCIS LTD | - |
dc.subject | GENOMIC STRUCTURE | - |
dc.subject | CANCER | - |
dc.subject | ANTIGENS | - |
dc.subject | THERAPY | - |
dc.subject | BINDING | - |
dc.subject | GENE | - |
dc.title | Production, characterization, and epitope mapping of monoclonal antibodies of ribosomal protein S3 (rpS3) | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Joon | - |
dc.identifier.doi | 10.1080/19768354.2021.1980100 | - |
dc.identifier.scopusid | 2-s2.0-85116478287 | - |
dc.identifier.wosid | 000704277500001 | - |
dc.identifier.bibliographicCitation | ANIMAL CELLS AND SYSTEMS, v.25, no.5, pp.323 - 336 | - |
dc.relation.isPartOf | ANIMAL CELLS AND SYSTEMS | - |
dc.citation.title | ANIMAL CELLS AND SYSTEMS | - |
dc.citation.volume | 25 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 323 | - |
dc.citation.endPage | 336 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002771755 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalResearchArea | Zoology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Zoology | - |
dc.subject.keywordPlus | ANTIGENS | - |
dc.subject.keywordPlus | BINDING | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordPlus | GENE | - |
dc.subject.keywordPlus | GENOMIC STRUCTURE | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordAuthor | Ribosomal protein subunit small 3 | - |
dc.subject.keywordAuthor | conformational epitope | - |
dc.subject.keywordAuthor | direct ELISA | - |
dc.subject.keywordAuthor | epitope mapping | - |
dc.subject.keywordAuthor | immunoprecipitation | - |
dc.subject.keywordAuthor | linear form epitope | - |
dc.subject.keywordAuthor | mAb | - |
dc.subject.keywordAuthor | peptide synthesis | - |
dc.subject.keywordAuthor | sandwich ELISA | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.